AnaptysBio Inc’s recent filing unveils that its Chief Medical Officer Lizzul Paul F. unloaded Company’s shares for reported $58005.0 on Sep 23 ’24. In the deal valued at $38.67 per share,1,500 shares were sold. As a result of this transaction, Lizzul Paul F. now holds 15,398 shares worth roughly $0.29 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, PAUL F LIZZUL bought 1,500 shares, generating $58,005 in total proceeds.
Before that, LOUMEAU ERIC J sold 8,720 shares. AnaptysBio Inc shares valued at $347,270 were divested by the CHIEF LEGAL OFFICER at a price of $39.82 per share. As a result of the transaction, LOUMEAU ERIC J now holds 7,020 shares, worth roughly $0.13 million.
H.C. Wainwright initiated its AnaptysBio Inc [ANAB] rating to a Buy in a research note published on July 22, 2024; the price target was $55. A number of analysts have revised their coverage, including JP Morgan’s analysts, who increased its forecast for the stock in mid July from “a Neutral” to “an Overweight”. Leerink Partners began covering ANAB with “an Outperform” recommendation on April 16, 2024. Wells Fargo started covering the stock on April 11, 2024. It rated ANAB as “an Overweight”.
Price Performance Review of ANAB
On Friday, AnaptysBio Inc [NASDAQ:ANAB] saw its stock fall -5.80% to $19.00. Over the last five days, the stock has lost -10.84%. AnaptysBio Inc shares have fallen nearly -11.30% since the year began. Nevertheless, the stocks have risen 32.04% over the past one year. While a 52-week high of $41.31 was reached on 08/14/24, a 52-week low of $13.36 was recorded on 04/25/24. SMA at 50 days reached $31.06, while 200 days put it at $27.84.
Levels Of Support And Resistance For ANAB Stock
The 24-hour chart illustrates a support level at 18.44, which if violated will result in even more drops to 17.89. On the upside, there is a resistance level at 20.03. A further resistance level may holdings at 21.07. The Relative Strength Index (RSI) on the 14-day chart is 26.23, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.81, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 99.34%. Stochastics %K at 7.19% indicates the stock is a buying.
How much short interest is there in AnaptysBio Inc?
A steep rise in short interest was recorded in AnaptysBio Inc stocks on 2024-10-31, growing by 0.22 million shares to a total of 6.18 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 5.96 million shares. There was a rise of 3.53%, which implies that there is a positive sentiment for the stock.
